Oncovia™ (Lumetrexan) is part of Zenovara Pharmaceuticals’ cutting-edge oncology portfolio, dedicated to delivering next-generation therapies for advanced and hard-to-treat cancers. • Colorectal Cancer – promising tumor response rates. • Pancreatic Cancer – Investigating its role in mutation-driven tumor suppression. • Brain Metastases – Early data suggests potential to cross the blood-brain barrier for enhanced efficacy. With a strong clinical foundation and continued innovation, Oncovia™ is paving the way for a new era in targeted cancer treatment. Transforming cancer care